Infectious diarrhoea

Paul Kelly,Phoebe Hodges

DOI: https://doi.org/10.1016/j.mpmed.2024.01.008

IF: 1.6

2024-02-01

Medicine

Abstract:Infectious diarrhoea remains a major cause of morbidity and mortality worldwide. Viruses, bacteria and protozoa are responsible for most infections, which are most commonly transmitted by the faecal–oral route through water, food and person-to-person transmission. The clinical presentation conforms to four patterns: acute watery diarrhoea; bloody diarrhoea (dysentery); persistent non-bloody diarrhoea, which can include steatorrhoea; and persistent bloody diarrhoea. Diagnosis still rests heavily on stool microscopy and culture, although faecal antigen tests and molecular assays are increasingly used. Oral rehydration therapy continues to be the most important supportive intervention, particularly in acute watery diarrhoea, in which death from dehydration and acidosis can be prevented in the vast majority of cases. There have been some important advances in the development of new approaches to antibiotic therapy. The non-absorbable antibiotic rifaximin is highly effective in the treatment of travellers' diarrhoea and has fewer adverse effects than systemically absorbed antibiotics. The broad-spectrum antimicrobial nitazoxanide is often effective in treating cryptosporidiosis but is also effective in giardiasis, amoebiasis and Clostridioides (Clostridium) difficile infection. Recent meta-analyses suggest that promicrobial therapies, including faecal microbial transplantation, have a place in the prophylaxis and treatment of antibiotic-associated diarrhoea, especially Clostridioides difficile infection, and acute diarrhoea in children.

medicine, general & internal